Molina Healthcare Inc. (MOH) stock plummeted over 9% in the pre-market trading session on Thursday, following the healthcare insurer's mixed fourth-quarter results and disappointing earnings guidance for 2025.
While Molina's Q4 revenue of $10.499 billion exceeded analysts' estimates, the company's adjusted earnings per share (EPS) of $5.05 missed the consensus forecast of $5.72. Higher-than-expected medical costs, particularly in the Medicaid business, were cited as the primary reason for the earnings shortfall. Molina's medical care ratio (MCR) rose to 90.2% in Q4, up from 89.1% a year ago, reflecting the impact of acuity shifts and increased utilization related to Medicaid redeterminations.
Furthermore, Molina's adjusted EPS guidance of at least $24.50 for 2025 fell short of analysts' expectations of around $26.07, despite the company forecasting revenue of approximately $44 billion, ahead of estimates. The weaker earnings outlook is attributed to anticipated costs associated with recent contract wins and acquisitions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.